Sarepta Therapeutics, Inc. · NASDAQ:SRPT
D. E. Shaw & Co., L.P. reported a 5.10% stake in Sarepta Therapeutics, Inc. (Schedule 13G/A)
Event Jul 18, 2025 · Filed Jul 25, 2025
D. E. Shaw & Co., L.P. reported a 5.10% stake in Sarepta Therapeutics, Inc., 5,059,912 shares, as a passive investor on Jul 18, 2025. Filed Jul 25, 2025 (Schedule 13G/A).
- Stake
- 5.10%
- Shares
- 5,059,912
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| D. E. Shaw & Co., L.P. | 5.10% | 5,059,912 |
| David E. Shaw | 5.10% | 5,059,912 |
Source
Related
- Sarepta Therapeutics, Inc.
- D. E. Shaw & Co., L.P.
- Sarepta Therapeutics, Inc. shareholders
- Schedule 13G/A · D. E. Shaw & Co., L.P. · Nov 14, 2025
- Schedule 13G · D. E. Shaw & Co., L.P. · Jul 25, 2025
- Form 4 · Wong Ryan Ho-Yan · Sep 8, 2026
- Form 4 · Estepan Ian Michael · Sep 8, 2026
- Form 4 · Rothfuss Cristin · Sep 8, 2026
- Form 4 · Rodino-Klapac Louise · Sep 8, 2026
- Schedule 13G/A · AQR Capital Management LLC · Aug 13, 2026